Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients

Cardiovascular Research

Volumn 97, Issue 2, 2013, Pages 369-378

  Jensen, Rebekka V ^a,b   Zachara, Natasha E ^c   Nielsen, Per H ^a   Kimose, Hans Henrik ^a   Kristiansen, Steen B ^a,b   Bøtker, Hans Erik ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus type 2; Ischaemia; O linked N acetylglucosamine (O GlcNAc); Remote ischaemic preconditioning; Reperfusion injury

Indexed keywords

AZASERINE; CARDIOVASCULAR AGENT; O LINKED BETA N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DIALYSATE LEVEL; DRUG BLOOD LEVEL; DRUG MECHANISM; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REPERFUSION INJURY;

ACETYLGLUCOSAMINE; AGED; BETA-N-ACETYLHEXOSAMINIDASES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMODYNAMICS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; N-ACETYLGLUCOSAMINYLTRANSFERASES;

EID: 84872503697     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs337     Document Type: Article

References (50)

1. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102:1014-1019.
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
3. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87:893-899.
4. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010;375:727-734.
5. Sivaraman V, Hausenloy DJ, Wynne AM, Yellon DM. Preconditioning the diabetic human myocardium. J Cell Mol Med 2010;14:1740-1746.
6. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2005;54:2360-2364.
7. Galagudza MM, Nekrasova MK, Syrenskii AV, Nifontov EM. Resistance of the myocardium to ischemia and the efficacy of ischemic preconditioning in experimental diabetes mellitus. Neurosci Behav Physiol 2007;37:489-493.
8. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT et al. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 2004;47:1716-1721.
9. Robinson KA, Weinstein ML, Lindenmayer GE, Buse MG. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 1995;44:1438-1446.
10. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991;266:4706-4712.
11. Vosseller K, Wells L, Lane MD, Hart GW. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 2002;99:5313-5318.
12. Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D et al. Insulindependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 2002;106:466-472.
13. Clark RJ, McDonough PM, Swanson E, Trost SU, Suzuki M, Fukuda M et al. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 2003;278:44230-44237.
14. Fulop N, Mason MM, Dutta K,Wang P, Davidoff AJ, Marchase RB et al. Impact of type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am J Physiol Cell Physiol 2007;292:C1370-C1378.
15. Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 2004;279:30133-30142.
16. Jones SP, Zachara NE, Ngoh GA, Hill BG, Teshima Y, Bhatnagar A et al. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 2008;117: 1172-1182.
17. Hu Y, Suarez J, Fricovsky E, Wang H, Scott BT, Trauger SA et al. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem 2009;284:547-555.
18. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307:384-387.
19. da Silva MM, Sartori A, Belisle E, Kowaltowski AJ. Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport. Am J Physiol Heart Circ Physiol 2003;285:H154-H162.
20. Wojtovich AP, Brookes PS. The endogenous mitochondrial complex II inhibitor malonate regulates mitochondrial ATP-sensitive potassium channels: implications for ischemic preconditioning. Biochim Biophys Acta 2008;1777:882-889.
21. Jensen RV, Stottrup NB, Kristiansen SB, Botker HE. Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol 2012;107:285.
22. Domenech R, Macho P, Schwarze H, Sanchez G. Exercise induces early and late myocardial preconditioning in dogs. Cardiovasc Res 2002;55:561-566.
23. Miyamae M, Camacho SA, Zhou HZ, Diamond I, Figueredo VM. Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats. Am J Physiol 1998;275:H50-H56.
24. Riksen NP, Zhou Z, Oyen WJ, Jaspers R, Ramakers BP, Brouwer RM et al. Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol 2006;48:700-707.
25. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001;89:1191-1198.
26. Ye Y, Perez-Polo JR, Aguilar D, Birnbaum Y. The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury. Basic Res Cardiol 2011;106: 925-952.
27. Ghosh S, Standen NB, Galinianes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001;37:711-718.
28. Heinen NM, Putz VE, Gorgens JI, Huhn R, Gruber Y, Barthuber C et al. Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning. Shock 2011;36:45-53.
29. Lyons SD, Sant ME, Christopherson RI. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia. J Biol Chem 1990;265:11377-11381.
30. Suzuki H, Kumagai H, Tochikura T. gamma-Glutamyltranspeptidase from Escherichia coli K-12: purification and properties. J Bacteriol 1986;168:1325-1331.
31. Hirose K, Tsutsumi YM, Tsutsumi R, Shono M, Katayama E, Kinoshita M et al. Role of the O-linked beta-N-acetylglucosamine in the cardioprotection induced by isoflurane. Anesthesiology 2011;115:955-962.
32. Ngoh GA, Watson LJ, Facundo HT, Jones SP. Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes. Amino Acids 2011;40: 895-911.
33. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 2008;294:C1509-C1520.
34. Tsujimoto Y, Nakagawa T, Shimizu S. Mitochondrial membrane permeability transition and cell death. Biochim Biophys Acta 2006;1757:1297-1300.
35. Argaud L, Gateau-Roesch O, Chalabreysse L, Gomez L, Loufouat J, Thivolet-Bejui F et al. Preconditioning delays Ca2+-induced mitochondrial permeability transition. Cardiovasc Res 2004;61:115-122.
36. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 2003;549:513-524.
37. Zhang SZ, Wang NF, Xu J, Gao Q, Lin GH, Bruce IC et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology 2006;105: 550-556.
38. Liu J, Marchase RB, Chatham JC. Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis. Am J Physiol Heart Circ Physiol 2007;293:H1391-H1399.
39. Steensrud T, Li J, Dai X, Manlhiot C, Kharbanda RK, Tropak M et al. Pretreatment with the nitric oxide donor SNAP or nerve transection blocks humoral preconditioning by remote limb ischemia or intra-arterial adenosine. Am J Physiol Heart Circ Physiol 2010; 299:H1598-H1603.
40. Tamareille S, Mateus V, Ghaboura N, Jeanneteau J, Croue A, Henrion D et al. RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol 2011;106: 1329-1339.
41. Wolfrum S, Schneider K, Heidbreder M, Nienstedt J, Dominiak P, Dendorfer A. Remote preconditioning protects the heart by activating myocardial PKCepsilonisoform. Cardiovasc Res 2002;55:583-589.
42. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 2012;110:111-115.
43. Dickson EW, Lorbar M, PorcaroWA, Fenton RA, Reinhardt CP, Gysembergh A et al. Rabbit heart can be 'preconditioned' via transfer of coronary effluent. Am J Physiol 1999;277:H2451-H2457.
44. Serejo FC, Rodrigues LF Jr, da Silva Tavares KC, de Carvalho AC, Nascimento JH. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. J Cardiovasc Pharmacol 2007;49:214-220.
45. Liu J, Marchase RB, Chatham JC. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol 2007; 42:177-185.
46. Ugurlucan M, Erer D, Karatepe O, Ziyade S, Haholu A, Gungor UF et al. Glutamine enhances the heat shock protein 70 expression as a cardioprotective mechanism in left heart tissues in the presence of diabetes mellitus. Expert Opin Ther Targets 2010;14:1143-1156.
47. Tong H, Chen W, London RE, Murphy E, Steenbergen C. Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by phosphatidylinositol 3-kinase. J Biol Chem 2000;275:11981-11986.
48. Lehman DM, Fu DJ, Freeman AB, Hunt KJ, Leach RJ, Johnson-Pais T et al. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 2005;54:1214-1221.
49. Bohm M, Pieske B, Ungerer M, Erdmann E. Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res 1989; 65:1201-1211.
50. Heidbuchel H, Vereecke J, Carmeliet E. Three different potassium channels in human atrium. Contribution to the basal potassium conductance. Circ Res 1990;66: 1277-1286.